Ironwood Pharmaceuticals (IRWD) Cash from Investing Activities Growth (1y) (2011 - 2025)
Ironwood Pharmaceuticals (IRWD) Cash from Investing Activities Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 13.93% |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 57.14% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -186.78% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 551.55% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 526.11% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | -3,664.79% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | -3.45% |
| 10 | Ironwood Pharmaceuticals | 644.00 Mn | 423.53 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 87.50% |
| Jun 30, 2025 | 96.55% |
| Mar 31, 2025 | 54.41% |
| Sep 30, 2024 | 99.93% |
| Jun 30, 2024 | 99.99% |
| Mar 31, 2024 | -423.08% |
| Dec 31, 2023 | -15,611.11% |
| Sep 30, 2023 | -34,180.30% |
| Jun 30, 2023 | -1,135,686.36% |
| Mar 31, 2023 | -44.44% |
| Dec 31, 2022 | 121.09% |
| Dec 31, 2021 | -357.14% |
| Dec 31, 2020 | 98.95% |
| Jun 30, 2020 | 84.52% |
| Mar 31, 2020 | -215.41% |
| Dec 31, 2019 | -115.22% |
| Sep 30, 2019 | -158.26% |
| Jun 30, 2019 | -117.11% |
| Mar 31, 2019 | -97.21% |
| Dec 31, 2018 | 153.90% |